Stoke Therapeutics, Inc. (STOK)
37.27
+1.93
(+5.46%)
USD |
NASDAQ |
Apr 17, 16:00
37.32
+0.05
(+0.13%)
After-Hours: 20:00
Stoke Therapeutics SG&A Expense (Quarterly) : 21.15M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biogen, Inc. | 682.50M |
| Krystal Biotech, Inc. | 41.45M |
| Scholar Rock Holding Corp. | 45.02M |
| Vertex Pharmaceuticals, Inc. | 487.00M |
| Zymeworks, Inc. | 15.43M |